Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Status unconfirmed · Has a placebo group

Conditions studied: Breast Cancer, Depression, Fatigue, Sleep Disorders

In brief

RATIONALE: Studying samples of blood in the laboratory from patients with breast cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue. PURPOSE: This research study is studying biomarkers associated with fatigue in patients with early-stage breast cancer treated with metformin or placebo on NCIC-CTG-MA.32.

Key facts

Study ID
NCT01286233
Run by
NSABP Foundation Inc
People needed
394
Starts
2011-07-01
Expected to finish
2016-09-01
Last updated by the study team
2015-09-09

Who can join

Age: 18 and older, up to 74. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.